TP3 – Absorption-Enhancing Lipid Formulations for Senolytics to Control Senescent Cells

TP3 works on developing improved formulations for senotherapeutics, which enhance bioavailability and minimize food-related absorption effects. The expected outcomes include reduced frailty, improved vascular viability, and potentially enhanced contractile and diastolic ventricular functions.